| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
5 companies
Zeldis Jerome B is a Director at Streamex Corp. with holdings across 5 companies. Recent SEC Form 4 filings include 7 buys and 7 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 24,000 | $51.50 | $1,235,897.49 | -21.9% | +1.5% | +50.7% | |
| Nov 20, 2024 | NXGL Nexgel, Inc. | Director | Buy | 3,636 | $2.75 | $9,999.00 | +3.5% | +9.7% | -50.9% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Director | Buy | 10,000 | $2.50 | $25,000.00 | +10.7% | +25.8% | -10.8% | |
| May 22, 2024 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 20,000 | $38.24 | $764,800.00 | -58.0% | -11.0% | +17.8% | |
| May 26, 2023 | NXGL Nexgel, Inc. | Director | Buy | 5,000 | $2.34 | $11,688.50 | +5.7% | -6.6% | +2.6% | |
| Mar 25, 2022 | NXGL Nexgel, Inc. | Director | Buy | 5,300 | $1.89 | $10,010.11 | +6.4% | -18.5% | -9.5% | |
| Dec 27, 2021 | NXGL Nexgel, Inc. | Director | Buy | 9,091 | $5.49 | $49,909.59 | +12.3% | -40.0% | -62.5% | |
| May 14, 2021 | SNGX Soligenix, Inc. | Director | Sell | 3,000 | $0.90 | $2,700.60 | -11.6% | +6.1% | -55.3% | |
| May 14, 2021 | SNGX Soligenix, Inc. | Director | Buy | 3,000 | $0.89 | $2,664.00 | +13.1% | +6.1% | -55.3% | |
| May 28, 2020 | STEX Streamex Corp. | Director | Buy | 1,000 | $10.49 | $10,488.90 | +0.9% | - | - |